South San Francisco, CA, United States of America

Sara Tanenbaum Schneider

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Ingenuity Systems, Inc., Qiagen Redwood City, Inc.. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sara Tanenbaum Schneider. Retrieved from https://idiyas.com/inventor/sara-tanenbaum-schneider

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2013)
  • San Francisco, CA (US) (2014)
  • S. San Francisco, CA (US) (2018)
  • South San Fransisco, CA (US) (2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sara Tanenbaum Schneider: Innovator in Drug Discovery Methods

Introduction

Sara Tanenbaum Schneider is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of drug discovery, holding a total of 4 patents. Her work focuses on identifying disease-related pathways that can lead to new drug targets and applications.

Latest Patents

Among her latest patents are innovative methods for identifying disease-related pathways. These methods can be utilized to identify drug discovery targets, discover new uses for existing drugs, and identify markers for drug response. Her contributions in this area are vital for advancing medical research and improving patient outcomes.

Career Highlights

Throughout her career, Sara has worked with notable companies such as Ingenuity Systems, Inc. and Qiagen Redwood City, Inc. Her experience in these organizations has allowed her to develop and refine her expertise in drug discovery methods.

Collaborations

Sara has collaborated with esteemed colleagues, including Richard O Chen and Raymond J Cho. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Sara Tanenbaum Schneider is a trailblazer in drug discovery methods, with a strong portfolio of patents and a commitment to advancing healthcare through her innovative work. Her contributions are shaping the future of medical research and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…